Back to results
US 2024/0002857 A1Published application
Double stranded rna targeting 17-beta hydroxysteroiddehydrogenase 13 (hsd17b13) and methods of use thereof
OwnerChunyang ZHANG, Zhongfa YANG +4inventors
InventorsChunyang ZHANG, Zhongfa YANG, Shiyu WANG, Weimin WANG, Chunxue ZHOU, Xiaochuan CAI
Life of this patent
Estimating the term…
Abstract
The disclosure relates to isolated oligonucleotides comprising duplex regions targeting hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13), and delivery systems, kits and compositions comprising same, and methods of using same for inhibiting or downregulating HSD17B13.
Claims29
An isolated oligonucleotide comprising a sense strand and an antisense strand, wherein:
- the sense strand comprises a nucleotide sequence that is substantially identical to a region comprising 19-25 nucleotides between any one of the nucleotide positions selected from:
- a) 229 to 249;
- b) 344 to 364;
- c) 474 to 496;
- d) 669 to 741;
- e) 882 to 947;
- f) 999 to 1032;
- g) 1101 to 1216;
- h) 1297 to 1326;
- and
- i) 1421 to 1507,
- from the 5′ end of a hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13) mRNA sequence according to SEQ ID NO:
- 1,
- and the antisense strand is substantially complementary to the sense strand such that the sense strand and the antisense strand together form a double stranded region.
11 more elements
(canceled)
(canceled)
(canceled)
-12. (canceled)
(canceled)
-26. (canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.